Status:
COMPLETED
Method of Fish Oil Administration on Patient Compliance
Lead Sponsor:
University of Mississippi, Oxford
Collaborating Sponsors:
Walgreens
Conditions:
Adverse Effects
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Many patients complain of fishy breath, upset stomach, or heartburn when taking the recommended amount of fish oil. A common recommendation made by pharmacists is to freeze the fish oil capsules to he...
Detailed Description
Fish oil has many proposed health benefits such as lowering triglycerides, decreasing inflammation, and reducing risk factors for cardiovascular disease. In order to take the recommended daily dose fo...
Eligibility Criteria
Inclusion
- Patients 18-65 years of age
- Minimal medication usage and controlled chronic health conditions
Exclusion
- Patients with significant renal, hepatic, autoimmune or gastrointestinal tract disease
- Patients with uncontrolled chronic health conditions (e.g., diabetes, high blood pressure, high cholesterol or hypothyroidism)
- Receiving prescription anti-coagulation, prescription anti-platelet, prescription anti-inflammatory drugs, biologics, chronic steroids, chemotherapy, or otherwise excessive medication regimens
- Pregnant/nursing women, \<18 years of age, prisoners, or the mentally ill
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01471366
Start Date
November 1 2011
End Date
July 1 2014
Last Update
July 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Mississippi School of Pharmacy
Jackson, Mississippi, United States, 39216